We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

58 hedge funds and large institutions have $34.6M invested in Vaxart in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

2% less funds holding

Funds holding: 59 → 58 (-1)

55% less capital invested

Capital invested by funds: $77.3M → $34.6M (-$42.7M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $516K

Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
1.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
18
Reduced
16
Closed
12
Calls
–
Puts
$516K
Net Calls
-$516K
Net Calls Change
-$341K

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$1.84M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.29M
3
Goldman Sachs
Goldman Sachs
New York
+$453K
4
California Public Employees Retirement System
California Public Employees Retirement System
California
+$441K
5
BIT
BlackRock Institutional Trust
California
+$387K

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$7.03M
2
6CM
683 Capital Management
New York
-$1.05M
3
TC
TFS Capital
Pennsylvania
-$646K
4
PA
Perceptive Advisors
New York
-$614K
5
U
UBS
Switzerland
-$515K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
$331K +$441K +10,559 New
B
27
Bailard
California
$328K – – –
BFA
28
BlackRock Fund Advisors
California
$263K +$2.63K +63 +0.8%
DMK
29
David M. Knott
$251K +$335K +8,009 New
SIM
30
Spark Investment Management
New York
$236K +$152K +3,627 +91%
BIM
31
Bogle Investment Management
Massachusetts
$235K +$21.9K +524 +8%
TC
32
TFS Capital
Pennsylvania
$197K -$646K -15,464 -71%
Northern Trust
33
Northern Trust
Illinois
$191K -$1.29K -31 -0.5%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$178K -$107K -2,569 -31%
WT
35
Wellcome Trust
United Kingdom
$137K +$183K +4,389 New
ARTA
36
A.R.T. Advisors
New York
$135K +$181K +4,337 New
Jane Street
37
Jane Street
New York
$108K -$3.55K -85 -2%
State Street
38
State Street
Massachusetts
$80K – – –
Charles Schwab
39
Charles Schwab
California
$75K – – –
GCP
40
GSA Capital Partners
United Kingdom
$70K +$25.1K +600 +36%
GF
41
Gabelli Funds
New York
$65K +$5.31K +127 +7%
VKH
42
Virtu KCG Holdings
New York
$55K +$73.6K +1,761 New
QI
43
Quotient Investors
New York
$49K +$65K +1,555 New
PP
44
PDT Partners
New York
$40K +$53.2K +1,273 New
Group One Trading
45
Group One Trading
Illinois
$38K +$17K +407 +51%
GC
46
Guggenheim Capital
Illinois
$37K -$4.93K -118 -9%
Bank of New York Mellon
47
Bank of New York Mellon
New York
$35K +$919 +22 +2%
CS
48
Credit Suisse
Switzerland
$33K -$160K -3,841 -78%
Millennium Management
49
Millennium Management
New York
$32K +$42.2K +1,010 New
BIM
50
BlackRock Investment Management
Delaware
$16K +$21.2K +508 New
1
2
3

VXRT Hedge Fund Activity: Q2 2014 in Review

58 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2014, worth a combined $34.6M — down 55% from $77.3M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of VXRT and 11 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 18 added.

The largest buyer was Broadfin Capital, adding an estimated $1.84M. The largest seller was HealthCor Management, exiting entirely with an estimated $7.03M sold.

  • 58 institutional investors held Vaxart (VXRT) as of Q2 2014, down from 59 in Q1 2014.
  • Funds reported $34.6M of Vaxart stock for Q2 2014, down 55% quarter-over-quarter.
  • 11 funds opened new Vaxart positions in Q2 2014 and 12 closed out, a net change of -1 holder.
  • The largest Vaxart buyer in Q2 2014 was Broadfin Capital, an estimated $1.84M added.
  • The largest Vaxart seller in Q2 2014 was HealthCor Management, an estimated $7.03M sold.

Based on aggregated 13F filings for Q2 2014.